Fatty acid synthase inhibitor orlistat impairs cell growth and down-regulates PD-L1 expression of a human T-cell leukemia line

G Cioccoloni, A Aquino, M Notarnicola… - Journal of …, 2020 - Taylor & Francis
Fatty Acid Synthase (FASN) is responsible for the de novo synthesis of fatty acids, which are
involved in the preservation of biological membrane structure, energy storage and assembly …

Overexpression of TOSO in CLL is triggered by B-cell receptor signaling and associated with progressive disease

CP Pallasch, A Schulz, N Kutsch… - Blood, The Journal …, 2008 - ashpublications.org
Resistance toward apoptotic stimuli mediated by overexpression of antiapoptotic factors or
extracellular survival signals is considered to be responsible for accumulation of malignant …

B-cell receptor triggers drug sensitivity of primary CLL cells by controlling glucosylation of ceramides

J Schwamb, V Feldhaus, M Baumann… - Blood, the journal of …, 2012 - ashpublications.org
Survival of chronic lymphocytic leukemia (CLL) cells is triggered by several stimuli, such as
the B-cell receptor (BCR), CD40 ligand (CD40L), or interleukin-4 (IL-4). We identified that …

Current Status of Novel Agents for the Treatment of B Cell Malignancies: What's Coming Next?

M Tannoury, D Garnier, SA Susin, B Bauvois - Cancers, 2022 - mdpi.com
Simple Summary Since the identification of a large variety of biomarkers in B cell
malignancies as being driving factors for tumor progression and patient prognosis, their …

[HTML][HTML] The PPARα agonist fenofibrate suppresses B-cell lymphoma in mice by modulating lipid metabolism

J Huang, SK Das, P Jha, W Al Zoughbi… - … et Biophysica Acta (BBA …, 2013 - Elsevier
Obesity is associated with an increased risk for malignant lymphoma development. We used
Bcr/Abl transformed B cells to determine the impact of aggressive lymphoma formation on …

The Role of Cholesterol in Chronic Lymphocytic Leukemia Development and Pathogenesis

AM White, OG Best, AK Hotinski, BJ Kuss, LA Thurgood - Metabolites, 2023 - mdpi.com
Cholesterol has many critical functions in cells. It is a key component of membranes and cell-
signalling processes, and it functions as a chemical precursor in several biochemical …

Development of a self-assembled nanoparticle formulation of orlistat, nano-ORL, with increased cytotoxicity against human tumor cell lines

TK Hill, AL Davis, FB Wheeler, SS Kelkar… - Molecular …, 2016 - ACS Publications
Fatty acid synthase (FASN), the enzyme that catalyzes de novo synthesis of fatty acids, is
expressed in many cancer types. Its potential as a therapeutic target is well recognized, but …

Fatty acid synthase inhibitor orlistat induces apoptosis in T cell lymphoma: role of cell survival regulatory molecules

S Kant, A Kumar, SM Singh - Biochimica et Biophysica Acta (BBA)-General …, 2012 - Elsevier
BACKGROUND: De novo fatty acid synthesis catalyzed by fatty acid synthase (FASN) is
crucial for tumor cell survival. Thus therapeutic targeting of FASN is considered as a novel …

Inhibition of protein geranylgeranylation specifically interferes with CD40-dependent B cell activation, resulting in a reduced capacity to induce T cell immunity

A Shimabukuro-Vornhagen, S Zoghi… - The Journal of …, 2014 - journals.aai.org
Ab-independent effector functions of B cells, such as Ag presentation and cytokine
production, have been shown to play an important role in a variety of immune-mediated …

Gene expression profiling identifies ARSD as a new marker of disease progression and the sphingolipid metabolism as a potential novel metabolism in chronic …

A Trojani, B Di Camillo, A Tedeschi… - Cancer …, 2012 - content.iospress.com
Background: Several studies demonstrated IGVH mutational status and ZAP70 expression
as the most relevant prognostic markers in Chronic Lymphocytic Leukemia (CLL) …